Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Research Abstract |
We examined the effects of VEGF-C156S, lymphangiogenesis inducer, and VEGFR3-Fc, lymphangiogenesis blocker, in murine models of viral myocarditis and cardiomyopathy with micro-catheters. We developed new treatment strategies for viral myocarditis and cardiomyopathy with limphangiogenesis factors in the heart.
|